Migraine Prophylaxis With Nortriptyline in Adults
Nortriptyline is not supported by good-quality controlled trial evidence for migraine prophylaxis in adults. Canadian Prophylactic Migraine Guidelines (2012)
Nortriptyline may be considered an off-label option based on expert opinion rather than evidence demonstrating efficacy. Canadian Prophylactic Migraine Guidelines (2012)
Core Recommendation for Adult Migraine Prevention
First-line preventive treatment is typically guided by agents with evidence from controlled trials (for example, antiepileptics, beta blockers, angiotensin receptor blockers, antidepressants with stronger evidence). American Headache Society (Preventive Migraine Treatment)
Nortriptyline is not recommended for routine use as migraine prophylaxis because controlled studies supporting efficacy were not identified in guideline review. Canadian Prophylactic Migraine Guidelines (2012)
Medication Selection Algorithm
Preventive options with trial support generally include the following drug classes: American Headache Society (Preventive Migraine Treatment)
- Antiepileptics (for example, topiramate, divalproex/valproate) American Headache Society (Preventive Migraine Treatment)
- Beta blockers (for example, propranolol, metoprolol) American Headache Society (Preventive Migraine Treatment)
- Angiotensin system agents (for example, candesartan) American Headache Society (Preventive Migraine Treatment)
- OnabotulinumtoxinA (for chronic migraine) American Headache Society (Preventive Migraine Treatment)
- CGRP-pathway therapies (for example, monoclonal antibodies, gepants) American Headache Society (Preventive Migraine Treatment)
- Tricyclic antidepressants: amitriptyline has stronger evidence than nortriptyline in guideline evidence maps. [1]
Key Evidence Supporting or Refuting Nortriptyline
A Canadian guideline review found no controlled studies supporting efficacy for nortriptyline (and other TCAs) in migraine prevention. Canadian Prophylactic Migraine Guidelines (2012)
The same guideline states no good evidence for TCAs other than amitriptyline, and that nortriptyline is “felt to be effective” only by expert opinion. Canadian Prophylactic Migraine Guidelines (2012)
An evidence map for preventive migraine interventions notes that no trials assessed nortriptyline. [1]
Monotherapy Versus Combination Therapy
Nortriptyline does not have trial-based efficacy support as a stand-alone preventive agent. Canadian Prophylactic Migraine Guidelines (2012)
Combination approaches are typically reserved for patients with inadequate response to evidence-supported monotherapy, using agents with established preventive efficacy. American Headache Society (Preventive Migraine Treatment)
Important Clarifications and Nuances
Amitriptyline is the tricyclic antidepressant with consistent trial evidence and is treated differently from nortriptyline in guideline evidence summaries. [1]
Nortriptyline is frequently used clinically, but guideline-reviewed evidence quality is lower than for better-supported preventive options. Canadian Prophylactic Migraine Guidelines (2012)
Initiation Thresholds for Preventive Therapy
Preventive therapy is generally considered when migraine frequency or disability is high enough to warrant reducing attack burden, consistent with mainstream headache society preventive-treatment guidance. American Headache Society (Preventive Migraine Treatment)
Common Pitfalls to Avoid
Selecting nortriptyline as routine preventive therapy risks low evidence strength compared with guideline-supported preventive classes. Canadian Prophylactic Migraine Guidelines (2012)
Relying on expert-opinion-only support for nortriptyline may delay escalation to agents with controlled-trial efficacy. Canadian Prophylactic Migraine Guidelines (2012)
Treatment Targets
A preventive strategy aims to reduce migraine frequency and migraine-related disability using interventions with demonstrated efficacy for migraine prevention. American Headache Society (Preventive Migraine Treatment)